Effect of nutrients, dietary supplements and vitamins on cognition: A systematic review and meta-analysis of randomized controlled trials

Canadian Geriatrics Journal

Volumn 18, Issue 4, 2015, Pages 231-245

  Forbes, Scott C ^a   Holroyd Leduc, Jayna M ^a,d   Poulin PhD, Marc J ^a,b   Hogan, David B ^a,b,c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Dementia; Macro nutrients; Micro nutrients; Nutrition

Indexed keywords

EID: 84969877243     PISSN: None     EISSN: 19258348     Source Type: Journal    
DOI: 10.5770/cgj.18.189     Document Type: Review

References (81)

1. Prince M, Guerchet, M, Prina, M. Alzheimer's Disease International. Policy brief for heads of government: the global impact of dementia 2013-2050. Alzheimer's Disease International. 2013. Available at: https://www.alz.co.uk/research/GlobalImpactDementia2013.pdf
2. Hurd MD, Martorell P, Delavande A, et al. Monetary costs of dementia in the United States. New Eng J Med. 2013;368(14):1326-34.
3. International WHO. aAD. Dementia: a public health priority. 2012. Available at: http://www.who.int/mental-health/publications/dementia-report-2012/en/.
4. Yaffe K, Vittinghoff E, Pletcher MJ, et al. Early adult to mid-life cardiovascular risk factors and cognitive function. Circulation. 2014;129:1548-50.
5. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. New Eng J Med. 2013;369(24):2275-77.
6. Schrijvers EM, Verhaaren BF, Koudstaal PJ, et al. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam study. Neurology. 2012;78(19):1456-63.
7. Qiu C, von Strauss E, B?ckman L, et al. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology. 2013;80(20):1888-94.
8. Matthews FE, Arthur A, Barnes LE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382(9902):1405-12.
9. Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med. 2010;153(3):176-81.
10. Brookmeyer R, Gray S. Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease. Stat Med. 2000;19(11-12):1481-93.
11. Morris MC, Evans DA, Bienias JL, et al. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology. 2004;62(9):1573-79.
12. Kalmijn S, van Boxtel MP, Ocke M, et al. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004;62(2):275-80.
13. Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2007;85(2):511-17.
14. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287(24):3223-29.
15. Devore EE, Grodstein F, van Rooij FJ, et al. Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010;67(7):819-25.
16. Slinin Y, Paudel ML, Taylor BC, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010;74(1):33-41.
17. Gillette-Guyonnet S, Secher M, Vellas B. Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol. 2013;75(3):738-55.
18. Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging. 2007;11(2):132-52.
19. Swaminathan A, Jicha GA. Nutrition and prevention of Alzheimer's dementia. Front Aging Neurosci. 2014;6:282.
20. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 5.1.0 (updated March 2011): The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12.
22. Manders M, de Groot LC, van Staveren WA, et al. Effectiveness of nutritional supplements on cognitive functioning in elderly persons: a systematic review. J Gerontol A Biol Sci Med Sci. 2004;59(10):M1041-49.
23. Jia X, McNeill G, Avenell A. Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2008;21(4):317-36.
24. Williams JW, Plassman BL, Burke J, et al. Preventing Alzheimer's disease and cognitive decline. Rockville (MD): Agency for Healthcare Research and Quality (US). Evidence report/technology assessment, No. 193. 2010. 727p. Available from: http://www.ncbi.nlm.nih.gov/books/NBK47456/.
25. The Consumer Food Trends Series. 2014. Available from: http://www.worldcat.org/title/consumer-food-trends-definingopportunities-for-albertas-agri-food-industry/oclc/802069366.
26. van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008;71(6):430-38.
27. Lee LK, Shahar S, Chin AV, et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology. 2013;225(3):605-12.
28. Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6(6):456-64.
29. Witte AV, Kerti L, Hermannst?dter HM, et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2014;24(11):3059-68.
30. Geleijnse JM, Giltay EJ, Kromhout D. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2012;8(4):278-87.
31. Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 longchain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr. 2010;91(6):1725-32.
32. Ford AH, Flicker L, Alfonso H, et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology. 2010;75(17):1540-47.
33. Kang JH, Cook N, Manson J, et al. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr. 2008;88(6):1602-10.
34. Walker JG, Batterham PJ, Mackinnon AJ, et al. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms-the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr. 2012;95(1):194-203.
35. de Jager CA, Oulhaj A, Jacoby R, et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012;27(6):592-600.
36. van Uffelen JG, Chinapaw MJ, van Mechelen W, et al. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br J Sports Med. 2008;42(5):344-51.
37. McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354(26):2764-72.
38. Stott DJ, MacIntosh G, Lowe GD, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr. 2005;82(6):1320-26.
39. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-88.
40. Kang JH, Cook N, Manson J, et al. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med. 2006;166(22):2462-68.
41. Kang JH, Cook NR, Manson JE, et al. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation. 2009;119(21):2772-80.
42. Park SK, Jung IC, Lee WK, et al. A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebocontrolled study. J Med Food. 2011;14(4):334-43.
43. Krikorian R, Nash TA, Shidler MD, et al. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr. 2010;103(5):730-34.
44. Krikorian R, Eliassen JC, Boespflug EL, et al. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci. 2010;13(3):116-22.
45. Grodstein F, Kang JH, Glynn RJ, et al. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med. 2007;167(20):2184-90.
46. Wolters M, Hickstein M, Flintermann A, et al. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation. Prev Med. 2005;41(1):253-59.
47. Macpherson H, Ellis KA, Sali A, et al. Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: A randomized controlled trial. Psychopharmacology. 2012;220(2):351-65.
48. Smith PJ, Blumenthal JA, Babyak MA, et al. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55(6):1331-38.
49. Rossom RC, Espeland MA, Manson JE, et al. Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc. 2012;60(12):2197-205.
50. Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009;5(3):140-52.
51. Hooijmans CR, Pasker-de Jong PC, de Vries RB, et al. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2012;28(1):191-209.
52. Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care. 2010;13(2):150-55.
53. Muldoon MF, Ryan CM, Sheu L, et al. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J. Nutr. 2010;140(4):848-53.
54. Spector R, Vesell ES. Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examples. J Clin Pharmacol. 2002;42(9):955-62.
55. Gomez-Pinilla F, Kostenkova K. The influence of diet and physical activity on brain repair and neurosurgical outcome. Surg Neurol. 2008;70(4):333-36.
56. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ. 2004;171(8):897-904.
57. Luchsinger JA, Tang MX, Miller J, et al. Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem Res. 2007;32(4-5):775-81.
58. Stroes ES, van Faassen EE, Yo M, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res. 2000;86(11):1129-34.
59. Kruman II, Kumaravel TS, Lohani A, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci. 2002;22(5):1752-62.
60. Meydani M, Hernandez-Rodriguez J, Youdim MBH, et al. Antioxidants and cognitive function. Nutr Rev. 2001;59(8-2):S75-82.
61. Butterfield DA, Castegna A, Lauderback CM, et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging. 2002;23(5):655-64.
62. Lee SY, Lee JW, Lee H, et al. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res Mol Brain Res. 2005;140(1-2):45-54.
63. Frölich L, Blum-Degen D, Bernstein HG, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm. 1998;105(4-5):423-38.
64. Hua Y, Clark S, Ren J, et al. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012;23(4):313-19.
65. Potischman N, Weed DL. Causal criteria in nutritional epidemiology. Am J Clin Nutr. 1999;69(6):1309S-14S.
66. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60(1):2-11.
67. Luchsinger JA, Tang MX, Miller J, et al. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007;64(1):86-92..
68. Rafnsson SB, Dilis V, Trichopoulou A. Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies. Eur J Nutr. 2013;52(6):1553-67.
69. Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. The Cochrane database of systematic reviews. 2012;6:CD005379.
70. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. The Cochrane database of systematic reviews. 2008(4):CD004514.
71. Loef M, Walach H. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. J Nutr Gerontol Geriatr. 2013;32(1):1-23.
72. Galan P, Brian?on S, Favier A, et al. Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? Br J Nutr. 2005;94(1):125-32.
73. Cheung BH, Ho IC, Chan RS, et al. Current evidence on dietary pattern and cognitive function. Adv Food Nutr Res. 2014;71:137-63.
74. Katz DL, Meller S. Can we say what diet is best for health? Annu Rev Public Health. 2014;35:83-103.
75. Gillette-Guyonnet S, Vellas B. Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):686-92.
76. Sacco RL. Achieving ideal cardiovascular and brain health: opportunity amid crisis: Presidential Address at the American Heart Association 2010 Scientific Sessions. Circulation. 2011;123(22):2653-57.
77. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol. 2013;74(4):580-91.
78. Singh B, Parsaik AK, Mielke MM, et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271-82.
79. Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging. 2013;17(6):544-52.
80. Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84(12):1318-25.
81. Middleton LE, Kirkland SA, Maxwell CJ, et al. Exercise: a potential contributing factor to the relationship between folate and dementia. J Am Geriatr Soc. 2007;55(7):1095-98.